Dr. Marty Makary, the FDA Commissioner, has stepped down, leaving the agency without confirmed leadership as it navigates the hantavirus outbreak on a cruise ship and several ongoing reviews of pharmaceutical safety. The FDA oversees products that account for about 20 cents of every dollar spent by Americans. Former officials from the FDA are openly voicing their worries regarding the perilous timing of this leadership void.
